---
title: "MapLight Therapeutics shareholders elect three directors at annual meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290685190.md"
description: "Maplight Therapeutics held its annual stockholder meeting on June 23, 2026. Shareholders elected three directors to serve until the 2029 annual meeting and approved RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026."
datetime: "2026-06-24T11:15:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290685190.md)
  - [en](https://longbridge.com/en/news/290685190.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290685190.md)
---

# MapLight Therapeutics shareholders elect three directors at annual meeting

-   Maplight Therapeutics held its annual stockholder meeting on June 23, 2026. \* Stockholders backed the selection of RSM US LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026. \* Stockholders elected three directors to serve until the 2029 annual meeting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-280243), on June 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MPLT.US](https://longbridge.com/en/quote/MPLT.US.md)

## Related News & Research

- [Maplight Therapeutics director Troy Cox reports purchase of 15,620 shares worth $148,702.4](https://longbridge.com/en/news/294132686.md)
- [Maplight Therapeutics (NASDAQ:MPLT) Director Acquires $148,702.40 in Stock](https://longbridge.com/en/news/294144422.md)
- [Kering announces availability of 2026 first-half report](https://longbridge.com/en/news/294091807.md)
- [Bicara Therapeutics director Christy J. Oliger files initial beneficial ownership statement](https://longbridge.com/en/news/294255131.md)
- [Aon posts Q2 2026 earnings presentation slides](https://longbridge.com/en/news/294204614.md)